Prosecution Insights
Last updated: April 19, 2026
Application No. 17/899,997

Home Care Compositions

Final Rejection §103§112
Filed
Aug 31, 2022
Examiner
OGDEN JR, NECHOLUS
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Colgate-Palmolive Company
OA Round
4 (Final)
70%
Grant Probability
Favorable
5-6
OA Rounds
2y 11m
To Grant
93%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allow Rate
714 granted / 1026 resolved
+4.6% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
42 currently pending
Career history
1068
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
49.1%
+9.1% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1026 resolved cases

Office Action

§103 §112
Response to Amendment Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 104-106, 108-123 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention are withdrawn. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 113 and 121 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. The aforementioned claims state that that the laureth sulfate has an average number of ethylene oxide of about 4.5. This does not further limit because the claims from which 113 and 121 depend state that the average number of ethylene oxide of laureth sulfate is between 0.4 and 0.6. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 Claim(s) 104-106, 108-115 is/are rejected under 35 U.S.C. 103 as being unpatentable over Hardy (9862913) is withdrawn. Response to Arguments Applicant’s arguments, filed 1-22-2026, with respect to claims 104-106 and 108-123 have been fully considered and are persuasive. The rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made. Allowable Subject Matter Claims 104-106, 108-112, 114-120, 122-123 are allowed. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NECHOLUS OGDEN JR whose telephone number is (571)272-1322. The examiner can normally be reached 8-4:30 EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached on 571-272-1498. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NECHOLUS OGDEN JR/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Aug 31, 2022
Application Filed
Feb 26, 2025
Non-Final Rejection — §103, §112
Jun 03, 2025
Response Filed
Jul 08, 2025
Final Rejection — §103, §112
Oct 08, 2025
Request for Continued Examination
Oct 12, 2025
Response after Non-Final Action
Oct 18, 2025
Non-Final Rejection — §103, §112
Jan 22, 2026
Response Filed
Feb 21, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595435
DETERGENT COMPOSITIONS
2y 5m to grant Granted Apr 07, 2026
Patent 12576019
PERSONAL CLEANSING COMPOSITION WITH AN ORGANIC ACID HAVING A PKA GREATER THAN 2.7
2y 5m to grant Granted Mar 17, 2026
Patent 12577502
USE OF PROPOXYLATED SURFACTANT OR POLYMER IN FOAMING APPLICATIONS TO CONTROL VISCOELASTICITY IN HIGHLY ACTIVE LIQUID FORMULATIONS
2y 5m to grant Granted Mar 17, 2026
Patent 12576013
DISSOLVABLE SOLID FIBROUS SHAMPOO ARTICLES CONTAINING SALTS
2y 5m to grant Granted Mar 17, 2026
Patent 12564549
CLEANSER COMPOSITION
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
70%
Grant Probability
93%
With Interview (+23.6%)
2y 11m
Median Time to Grant
High
PTA Risk
Based on 1026 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month